| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.1.1 | To recall the terminologiesin the human anatomy and physiology, along with learn the functions of human cell |
| 2 | C1.1.2 | To summarize the functions of tissue, bones and joints in the skeleton. |
| 3 | C1.1.3 | To explain the functions of formed elements in the bloodalong with lymph and its role in immunity |
| 4 | C1.1.4 | To compare the anatomical features of heart, lungs and GIT and to analyze their physiology. |
| 5 | C1.1.5 | To assess the structure and function of brain, spinal cord andcranial nerves and to interpret the physiology of urinary system. |
| 6 | C1.1.6 | To elaborate the physiology of endocrine glands, reproductive organs, sensory organs and to discuss the physiology skeletal muscles. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.1.1 | To find and relate characteristics of various tissues of human body |
| 2 | C1.1.2 | To demonstrate bleeding time, clotting time, blood pressure and blood grouping. |
| 3 | C1.1.3 | To identify the number of RBC and WBC using hemocytometer |
| 4 | C1.1.4 | To examine the functions of various organ systems in human body |
| 5 | C1.1.5 | To interpret the mechanisms of pregnancy diagnosis tests and various family planning appliances |
| 6 | C1.1.6 | To construct and record simple curves using frog gastroenemius sciatic nerve |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.2.1 | To define the profession of pharmacy and pharmacopoeias. |
| 2 | C1.2.2 | To outline the classification of dosage forms, summarize importanceof prescription and posology. |
| 3 | C1.2.3 | To develop monophasic and biphasic liquid dosage forms. |
| 4 | C1.1.4 | To simplify the preparation of suppositories and powders. |
| 5 | C1.2.5 | To explain the concepts of surgical aids and galenicals. |
| 6 | C1.2.6 | To elaborate the importance of pharmaceutical incompatibilities and solve calculations. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.2.1 | To remember the principles used in the preparation of liquid, semisolid and solid dosage forms. |
| 2 | C1.2.2 | To illustrate monophasic internal and external liquid dosage forms. |
| 3 | C1.2.3 | To experiment with biphasic liquid dosage forms. |
| 4 | C1.2.4 | To take part in formulation of powder dosage forms. |
| 5 | C1.2.5 | To appraise the formulation of suppositories. |
| 6 | C1.2.6 | To solve the prescriptions having the incompatibility problems. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.3.1 | To recall the importance of biochemistry, catalytic activity, mechanism of action and applications of enzymes. |
| 2 | C1.3.2 | To understand the metabolism of carbohydrates, lipids, electron transport chain and ATP formation. |
| 3 | C1.3.3 | To apply the clinical chemistry knowledge in diagnosis and prognosis of diseases. |
| 4 | C1.3.4 | To simplify the metabolism and disorders associated with nucleic acids and amino acids. |
| 5 | C1.3.5 | To interpret the genetic organization of mammalian genome, study protein synthesis and DNA replication. |
| 6 | C1.3.6 | To elaborate the knowledge on immunochemical techniques and their applications. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.3.1 | To remember the qualitative analysis of urine and confirmatory test for carbohydrates. |
| 2 | C1.3.2 | To understand the quantitative estimation and clinical significance of constituents like glucose, creatinine, calcium and chlorides in urine. |
| 3 | C1.3.3 | To experiment with estimation of glucose, creatinine, urea, uric acid in blood and their clinical significance |
| 4 | C1.3.4 | To perform the liver function tests and lipid profile tests. |
| 5 | C1.3.5 | To determine the enzymatic hydrolysis of starch and influence of factors like pH and temperature on enzyme activity. |
| 6 | C1.3.6 | To discuss the preparation of standard buffer solutions and their pH measurements. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.4.1 | To recall the nomenclature, properties and isomerism in organic compounds |
| 2 | C1.4.2 | To explain the preparation, reactions and stability of alkanes and alicyclic compounds |
| 3 | C1.4.3 | To study the kinetics, mechanism, stereochemistry of free radical, electrophilic, nucleophilic addition reactions and theory of resonance |
| 4 | C1.4.4 | To compare reactivity, orientation and factors influencing aliphatic nucleophilic substitution with aromatic nucleophilic substitution |
| 5 | C1.4.5 | To explain the mechanism and applications of selected named reactions |
| 6 | C1.4.6 | To discuss the method of preparation, test for purity, assay and medicinal uses of selected organic compounds |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.4.1 | To recall and show the stereo models of organic compounds |
| 2 | C1.4.2 | To outline the preliminary tests and detection of elements for qualitative analysis |
| 3 | C1.4.3 | To apply the laboratory techniques involved in synthesis of organic compounds |
| 4 | C1.4.4 | To analyze the organic compounds and identify the functional groups by systematic qualitative analysis |
| 5 | C1.4.5 | To explain the synthesis and characterization of selected organic compounds |
| 6 | C1.4.6 | To discuss the appropriate method of purification of organic compounds |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.5.1 | To recall the errors in pharmaceutical analysis and principles of volumetric analysis |
| 2 | C1.5.2 | To understand acid-base titrations and limit tests for inorganic compounds |
| 3 | C1.5.3 | To select the appropriate titrimetric method for analysis of drugs |
| 4 | C1.5.4 | To classify and study the method of preparation and assay of selected inorganic compounds |
| 5 | C1.5.5 | To explain the importance of inorganic pharmaceuticals in preventing and curing the disease |
| 6 | C1.5.6 | To discuss the radioisotopes and applications of radiopharmaceuticals |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.5.1 | To recall the glassware and apparatus used in volumetric analysis |
| 2 | C1.5.2 | To explain the limit test for impurities in inorganic compounds |
| 3 | C1.5.3 | To make use of volumetric methods for performing assays |
| 4 | C1.5.4 | To analyze selected inorganic compounds by different titrimetric methods |
| 5 | C1.5.5 | To estimate the compounds present in a mixture |
| 6 | C1.5.6 | To perform test for identity of selected inorganic compounds |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.6.1 | To recall the importance of mathematics in pharmacy |
| 2 | C1.6.2 | To outline the various topics in mathematics |
| 3 | C1.6.3 | To utilize mathematical equations in doing problems |
| 4 | C1.6.4 | To take part in solving problems by applying the concepts |
| 5 | C1.6.5 | To appraise the important applications of mathematics |
| 6 | C1.6.6 | To solve and convert elementary functions using Laplace transform |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C1.6.1 | To understand the basic experiments in Biology and to list out the parts in cell |
| 2 | C1.6.2 | To demonstrate the preparation of permanent slides, section cutting techniques & different staining methods |
| 3 | C1.6.3 | To improve knowledge on identification of various animal and plant specimens |
| 4 | C1.6.4 | To distinguish the various plant by microscopically examination of roots, stems, fruits, leaf and seeds |
| 5 | C1.6.5 | To assess the plant taxonomy based on macroscopic and microscopy findings |
| 6 | C1.6.6 | To create experiments on the plant physiology |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.1.1 | To understand the process of cell injury by various etiological agents, morphology of cell injury and cellular adaptations. |
| 2 | C2.1.2 | To summarize the events of acute and chronic inflammation and to relate them to the process of wound healing. |
| 3 | C2.1.3 | To apply the knowledge of immune tolerance and Human Leucocytic antigen system in understanding the process of organ transplantation, autoimmunity and hypersensitivity reactions. |
| 4 | C2.1.4 | To assess the need of balanced diet and the effect of radiation and air pollution on human body. |
| 5 | C2.1.5 | To appraise the principles of physical, chemical and biologic carcinogenesis and to evaluate the pathological changes observed in a cancer tissue. |
| 6 | C2.1.6 | To adapt the principles of cell injury, inflammation and immune- pathology in understanding pathogenesis of various disease states and their clinical features and complications. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.2.1 | To list the branches, scope of microbiology and morphology of microbes. |
| 2 | C2.2.2 | To explain the methods of identification, cultivation and preservation of various microorganisms. |
| 3 | C2.2.3 | To apply the principles of sterilization in pharmaceutical processing and sterility testing. |
| 4 | C2.2.4 | To compare different types of immunological reactions, antigens, vaccines and their role in immunity. |
| 5 | C2.2.5 | To evaluate microbiological standards of pharmaceuticals and presence of pathogens. |
| 6 | C2.2.6 | To elaborate the characteristics, mode of infection, diagnosis, prophylaxis and treatment of bacterial, fungal and viral infectious agents. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.2.1 | To recall different techniques of sterilization and equipment used in microbiology laboratory. |
| 2 | C2.2.2 | To interpret characteristics of microbes using staining techniques, isolation methods and quantitative estimation. |
| 3 | C2.2.3 | To construct standard graphs for estimating antibiotics and vitamins using microbes. |
| 4 | C2.2.4 | To test for possible microbial contamination in a given sample. |
| 5 | C2.2.5 | To estimate qualitatively and quantitatively the amount of microbes in a sample. |
| 6 | C2.2.6 | To choose the correct method for evaluating the microbes by serological and bacteriological methods. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.3.1 | To define and introduce the history, scope and classification of crude drugs |
| 2 | C2.3.2 | To explain and relate about the cultivation, collection, processing and storage of crude drugs |
| 3 | C2.3.3 | To apply the knowledge of microscopical for studying properties of cell constituents |
| 4 | C2.3.4 | To compare and classify the natural pesticides |
| 5 | C2.3.5 | To determine and evaluate the importance of carbohydrates, proteins, lipids and fibers along with their pharmacognistic study |
| 6 | C2.3.6 | To estimate and predict the types of adulteration of crude drugs |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.3.1 | To understand collection and preparation of crude drugs and to recall selected crude drugs. |
| 2 | C2.3.2 | To understand microscopic study and the methods of quality control for crude drugs with WHO guidelines. |
| 3 | C2.3.3 | To perform the transversection of the crude drugs for identification. |
| 4 | C2.3.4 | To identify crude drugs by chemical tests: Tragacanth, Acacia, Agar, Gelatin, Starch, Honey and lipids. |
| 5 | C2.3.5 | To evaluate the crude drugs for adulteration by macroscopic features. |
| 6 | C2.3.6 | To estimateacid value, saponification value, ester value, iodine value and extractive values of crude drugs. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.4.1 | To define the fundamental concepts of pharmacology, pharmaco kinetics and to understand the basics of drugs interactions, drug discovery and toxicity studies. |
| 2 | C2.4.2 | To classify the role of neurotransmitter in autonomic nervous system and summarize the drugs action on it. |
| 3 | C2.4.3 | To organize the pharmacology of the drugs acting on cardiovascularsystem. |
| 4 | C2.4.4 | To analyze the role of neurotransmitter in central nervous system and summarize the drugs action on CNS and respiratory system. |
| 5 | C2.4.5 | To appraise the physiological role of hormones and assess the therapeutic effects of its replacement therapy. |
| 6 | C2.4.6 | To predict the role of autocoids in pathological conditions and their importance in treating various diseases. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.5.1 | To recollect the parts of prescription and study the concepts of pharmaceutical care. |
| 2 | C2.5.2 | To understand the scope of community pharmacy, site selection, space layout, legal requirements and inventory management of community pharmacy. |
| 3 | C2.5.3 | To identify the best way of improving medication adherence and to excel in conducting patient counseling. |
| 4 | C2.5.4 | To survey the health status of patients in the community by participating on health screening services and to build the ability to manage minor ailments. |
| 5 | C2.5.5 | To explain the importance of rational drug therapy, OTC medication counseling and code of ethics to became a competent pharmacist. |
| 6 | C2.5.6 | To improve the professional skills about health, balance diet, family planning, health promotion and prevention of communicable diseases in community. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.6.1 | To recall the pathophysiology of cardiovascular disorders and relate their etiology with the therapeutic approach including treatment controversies. |
| 2 | C2.6.2 | To outline the concept of essential drugs use and rational drug therapy and summarize the choice of drugs with justification in various disease conditions. |
| 3 | C2.6.3 | To identify various types of respiratory and endocrine disorders with respect to clinical features and laboratory investigations, list their complications along with replacement in their management. |
| 4 | C2.6.4 | To distinguish between various disease conditions and analyze the results with drug induced disorders. |
| 5 | C2.6.5 | To select the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy among pediatric, geriatric, pregnant and lactating women. |
| 6 | C2.6.6 | To develop competency to design individual care plan for cardiovascular, respiratory, ocular and hormonal disorders. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C2.6.1 | To list the sign and symptoms, laboratory parameters of the cardiovascular diseases. |
| 2 | C2.6.2 | To identify the drug interactions and find a solutions to overcome drug interactions in the given prescriptions. |
| 3 | C2.6.3 | To plan an individual care plan in the cases with endocrine and thyroid disorders. |
| 4 | C2.6.4 | To analyze the prescription for rational drug use. |
| 5 | C2.6.5 | To explain the safety of oral contraceptives, hormone replacement therapy and the drugs used on occular disorder |
| 6 | C2.6.6 | To minimize the drug related problems in the prescriptions and to choose a choice of drugs in various diseases. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.1.1 | To list the various drugs acting on bloodand blood forming agents |
| 2 | C3.1.2 | To classify drugs acting on renal system and explain the mechanism adverseeffects & therapeuticuses of drugs. |
| 3 | C3.1.3 | To develop the knowledge on principles of chemotherapy and treatment for various microbial infections. |
| 4 | C3.1.4 | To assume the role of immunotherapeutic agents and distinguish acute, sub-acute and chronic animal toxicity studies |
| 5 | C3.1.5 | To predict the structure and functions of the components of the cell, role of secondary messengers in cell signaling and determine the structure of chromosome |
| 6 | C3.1.6 | To compile the role of genetic material in synthesis of proteins. The appropriateness of gene therapy and recombinant DNA technology. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.1.1 | To recall the different laboratory animals, laboratory appliances, physiological salt solutions and anesthetic agents used in experimental pharmacology. |
| 2 | C3.1.2 | To demonstrate the different animal handling techniques, routes of administration of drugs to experimental animals. |
| 3 | C3.1.3 | To apply knowledge on the various bio-assay and improve techniques to construct DRC by using standard drugs |
| 4 | C3.1.4 | To analyse the data obtained from various animal experiments and compare the potency of test compound |
| 5 | C3.1.5 | To assesspharmacological action of minor and major tranquillizers with the experimental animal models |
| 6 | C3.1.6 | To evaluate the cardiotonic activity of drugs using isolated frog heart preparations. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.2.1 | To recall the principle and theory of instrumental analytical techniques |
| 2 | C3.2.2 | To outline the instrumentation of spectroscopic, chromatographic and thermal techniques |
| 3 | C3.2.3 | To apply the knowledge of spectroscopic, chromatographic and thermal methods in analysis of drugs |
| 4 | C3.2.4 | To analyze API’s and formulation by using elements of interpretation of data |
| 5 | C3.2.5 | To explain theory, instrumentation and applications of electrometric methods of analysis |
| 6 | C3.2.6 | To maximize knowledge on concepts of validation, calibration, ICH, GLP, ISO9000, TQM and quality variation concepts |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.2.1 | To recall the separation and identification of compounds by chromatographic techniques |
| 2 | C3.2.2 | To explain the qualitative and quantitative analysis of drugs by spectroscopic techniques |
| 3 | C3.2.3 | To experiment with instrumental analysis of selected drugs as per pharmacopoeia |
| 4 | C3.2.4 | To compare and characterize compounds by using analytical techniques |
| 5 | C3.2.5 | To determine concentration of ions by electrometric analysis |
| 6 | C3.2.6 | To discuss the instrumentation, applications of advanced analytical techniques and to interpret spectral data |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.3.1 | To remember and recall the pathophysiology of selected diseases and rationale for drug therapy. |
| 2 | C3.3.2 | To identify various therapeutic approaches for the management of selected diseases. |
| 3 | C3.3.3 | To apply the concepts of various drug therapies and identify the controversies in drug therapy. |
| 4 | C3.3.4 | To assess the drug therapy by preparing individual therapeutic plan based on diagnosis. |
| 5 | C3.3.5 | To evaluate the patient specific parameters relevant in initiating drug therapy and monitoring therapy. |
| 6 | C3.3.6 | To create a pharmaceutical care plan, design a list of patient counselling points on the specific illness. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.3.1 | To remember and recall the pathophysiology and management of cardiovascular, respiratory ,endocrine diseases and viral infections |
| 2 | C3.3.2 | To identify various drug interactions and rationalize the prescription. |
| 3 | C3.3.3 | To plan the quality use of medicines surrounding the therapeutic agents in the treatment of selected diseases |
| 4 | C3.3.4 | To analyze the clinical skills in the therapeutic management of selected disease conditions |
| 5 | C3.3.5 | To prioritize the treatment strategies for better patient outcome and discuss the controversies in treatment |
| 6 | C3.3.6 | To improve the skills on patient – centred approach to improve treatment satisfaction and perform patient counselling |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.4.1 | To recall the concepts of pharmaceutical legislations in India and code of pharmaceutical ethics |
| 2 | C3.4.2 | To outline the schedules and provisions given under Drugs and Cosmetics act 1940 and its rules 1945 |
| 3 | C3.4.3 | To apply the provisions of Pharmacy act 1948 and procedure for registration of pharmacist |
| 4 | C3.4.4 | To list out the provisions under medicinal and toilet preparations act, narcotic drugs and psychotropic substances act and rules, drugs and magic remedies act and rules |
| 5 | C3.4.5 | To understand the importance of Essential commodities act and National drug policy |
| 6 | C3.4.6 | To discuss the salient features of Prevention of cruelty to animals act 1960 and Patents and design act 1970 |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.5.1 | To recall the various classes of medicinal compounds |
| 2 | C3.5.2 | To outline the drugs used as chemotherapeutic agents |
| 3 | C3.5.3 | To identify the structural features of drugs required for activity and study their mechanism of action |
| 4 | C3.5.4 | To plan for the synthesis of selected category of drugs and their clinical uses |
| 5 | C3.5.5 | To explain the importance of diagnostic agents and concept of anti-sense molecules |
| 6 | C3.5.6 | To discuss the QSAR studies, combinatorial chemistry and CADD techniques used in rational drug design |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.5.1 | To recall the basic requirements for synthesis of medicinal compoun ds |
| 2 | C3.5.2 | To explain the principle and techniques involved in synthesis of drugs |
| 3 | C3.5.3 | To apply the various methods for quantitative analysis of drugs |
| 4 | C3.5.4 | To analyze medicinal compounds and study their pharmacopoeial monographs |
| 5 | C3.5.5 | To determine the percentage purity of marketed formulations |
| 6 | C3.5.6 | To estimate the physicochemical parameters for QSAR analysis |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.6.1 | To recall the basic concepts of pharmaceutical dosage forms. ds |
| 2 | C3.6.2 | To explain formulation, coating and evaluation of tablets. |
| 3 | C3.6.3 | To develop and examine capsule dosage forms. |
| 4 | C3.6.4 | To simplify the formulation, evaluation and stability considerations of liquid orals. the preparation and quality control of parenteral preparations. |
| 5 | C3.6.5 | To appraise parenteral, ophthalmic, semisolids products and packaging material. |
| 6 | C3.6.6 | To design various sustained and controlled drug delivery systems. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C3.6.1 | To recall the preparation and evaluation of compressed tablets ds |
| 2 | C3.6.2 | To illustrate the basic requirements for formulation and evaluation of capsules. |
| 3 | C3.6.3 | To develop parenteral formulations. |
| 4 | C3.6.4 | To take part in formulation of liquid orals. |
| 5 | C3.6.5 | To justify the use of excipients and formulate of semisolid dosage forms. |
| 6 | C3.6.6 | To develop various cosmetic preparations. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.1.1 | To remember the etiopathogenesis and clinical presentation of gastrointestinal and haematological diseases. ds |
| 2 | C4.1.2 | To summarize the diagnosis and therapeutic approaches of gastrointestinal and haematological diseases. |
| 3 | C4.1.3 | To identify the causes, pathogenesis and clinical manifestations of neurological and psychiatric diseases. |
| 4 | C4.1.4 | Tosimplify understanding on diagnosis, desired outcomes and management of neurological and psychiatric diseases |
| 5 | C4.1.5 | To explain the physiology of pain pathway and management of pain, neuralgia and headaches. |
| 6 | C4.1.6 | To develop skills on evidence-based practice in diseases management to become a competent pharmacist. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.1.1 | To und erstand the therapeutic approaches and treatment alternatives in the management of gastrointestinal diseases. |
| 2 | C4.1.2 | Torelate the concept of pharmaceutical care to identify therapeutic problems in haematological diseases. |
| 3 | C4.1.3 | To apply the knowledge to develop therapeutic decision-making skills in gastrointestinal and haematological diseases. |
| 4 | C4.1.4 | To take part in drug related problem identification and problem-solving skills in neurological diseases |
| 5 | C4.1.5 | To prioritize the rational pharmacotherapeutic alternatives in the management of psychiatric diseases. |
| 6 | C4.1.6 | To develop skills on drug of choice and patient education in management of diseases. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.2.1 | To define the structure, organization and functions of hospital and hospital pharmacist |
| 2 | C4.2.2 | To understand and involve in the preparation and implementation of budget, inventory control various drug policies |
| 3 | C4.2.3 | To make use of various hospital drug policies to develop hospital pharmacy news letters |
| 4 | C4.2.4 | To list out various drug distribution methods for inpatients and outpatients including narcotic and controlled drugs. |
| 5 | C4.2.5 | To prioritize the procurement, manufacturing and storage process of various formulations and handling of radio pharmaceuticals |
| 6 | C4.2.6 | To develop programmes for professional upraising continuously and to build inter professional relations in the hospitals. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.2.1 | To understand various drug distribution systems in hospital. |
| 2 | C4.2.2 | To extend the professional practice management skills in hospital pharmacy. |
| 3 | C4.2.3 | To utilize various methods for the preparation and labelling of pharmaceutical products such as powders and intravenous solutions |
| 4 | C4.2.4 | To recommend the solutions to overcome the drug interaction and adverse drug reactions. |
| 5 | C4.2.5 | To appreciate various store management and inventory control. |
| 6 | C4.2.6 | To solve drug related problems through prescription analysis and individualized dose. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.3.1 | To understand and explain the daily activities of clinical pharmacist and to monitor the patient rug therapy through medication chart review and clinical review. |
| 2 | C4.3.2 | To obtain medication history interview and counsel the patients on various diseases and lifestyle modifications and by applying communication skills. |
| 3 | C4.3.3 | To provide response to a drug and poison information queries using modified systemic approach and to gain ability to establish a drug and poison information center. |
| 4 | C4.3.4 | To interpret selected laboratory results of specific disease states mentioned and to report ADRs and understand the process of pharmacovigilance. |
| 5 | C4.3.5 | To identify and resolve drug related problems and medication errors. |
| 6 | C4.3.6 | To critically evaluate biomedical literature in order to get an unbiased clinical evidence to develop individualized pharmaceutical care plan. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.3.1 | To create awareness in patients by counselling them on various diseases and drugs using clinical knowledge and communication skills. |
| 2 | C4.3.2 | To conduct comprehensive and meticulous medication history interview for the preparation of individualized pharmaceutical care plan. |
| 3 | C4.3.3 | To interpret laboratory results of specific disease states mentioned and correlating with patient drug therapy while monitoring disease progression. |
| 4 | C4.3.4 | To provide response to a drug and poison information queries using modified systemic approach by critically appraising the biomedical literature. |
| 5 | C4.3.5 | To report and assess causality of adverse drug reactions to establish a causal relation between an ADR and a drug. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.4.1 | To define the concepts of research methodology and sample size determination with report writing. |
| 2 | C4.4.2 | To discuss different types of clinical study designs involved in medical research like case studies, observational studies and interventional studies. |
| 3 | C4.4.3 | To apply the concepts of biostatistics and data graphics along with clinical soft wares like SPSS, SAS to support the research design. |
| 4 | C4.4.4 | To learn to utilize the computer applications and their advantages in both hospital, community pharmacy. |
| 5 | C4.4.5 | To simplify the understanding of statistical methods in epidemiology and be conscious about its relative, attributable risks |
| 6 | C4.4.6 | To critically evaluate biomedical literature in order to get an unbiased clinical evidence to develop individualized pharmaceutical care plan. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.5.1 | To recall basic concepts of absorption, distribution, metabolism and excretion of drugs. |
| 2 | C4.5.2 | To understand the mechanisms, interpret various factors affecting drug absorption, distribution, metabolism and excretion of drugs. |
| 3 | C4.5.3 | To apply the pharmacokinetic models for the determination of pharmacokinetic parameters. |
| 4 | C4.5.4 | To examine multiple dosage regimens based on pharmacokinetic parameters for maximizing therapeutic effectiveness and patient compliance. |
| 5 | C4.5.5 | To evaluate various pharmacokinetic parameters for the drugs exhibiting saturation kinetics. |
| 6 | C4.5.6 | To design the bioavailability testing protocol of a drug and compare the bioequivalence between marketed products. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.5.1 | To recall the concepts in biopharmaceutics, basic pharmacokinetic parameters and their significance. |
| 2 | C4.5.2 | To interpret the effect of surfactant, diluents, lubricant and polymorphism on rate of drug dissolution. |
| 3 | C4.5.3 | To solve bioavailability parameters of drugs by using plasma data and methods to improve bioavailability. |
| 4 | C4.5.4 | To analyze absorption rate constant, KE, biological half-life, mean residence time and mean absorption time for the given data. |
| 5 | C4.5.5 | To estimate the extent of protein biding by equilibrium dialysis or dynamic dialysis methods. |
| 6 | C4.5.6 | To predict the pharmacokinetic parameters for the given data as per one compartment and two compartment models. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.6.1 | To understand the general principles involved in the management of poisoning with toxicokinetics parameters. |
| 2 | C4.6.2 | To identify the role of antidotes, supportive care, gut decontamination and elimination enhancement in poisoning. |
| 3 | C4.6.3 | To distinguish the clinical symptoms and to plan various managements of pesticides, drugs acting on CNS, hydrocarbons, caustics and radiation poisoning. |
| 4 | C4.6.4 | To categorize the toxic symptoms and management of venomous snake bites, toxicity of plants and contaminated foods and heavy metals. |
| 5 | C4.6.5 | To compare the characteristics and specific standard treatment guideline for the treatment of various toxins. |
| 6 | C4.6.6 | To propose several preventive approaches to reduce unintended poisoning. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.7.1 | To remember and recall the pathophysiology of selected diseases and rationale for drug therapy. |
| 2 | C4.7.2 | To identify various therapeutic approaches for the management of selected diseases. |
| 3 | C4.7.3 | To apply the concepts of various drug therapies and identify the controversies in drug therapy. |
| 4 | C4.7.4 | To distinguish between various disease conditions and analyze the results with drug induced disorders. |
| 5 | C4.7.5 | To select the patient-specific parameters relevant in initiating drug therapy, and monitoring therapy among pediatric, geriatric, pregnant and lactating women. |
| 6 | C4.7.6 | To develop competency to design individual care plan for cardiovascular, respiratory, ocular and hormonal disorders. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C4.7.1 | To remember and recall the pathophysiology and management of cardiovascular, respiratory, endocrine diseases and viral infections |
| 2 | C4.7.2 | To identify various drug interactions and rationalize the prescription. |
| 3 | C4.7.3 | To plan the quality use of medicines surrounding the therapeutic agents in the treatment of selected diseases |
| 4 | C4.7.4 | To analyze the clinical skills in the therapeutic management of selected disease conditions |
| 5 | C4.7.5 | To prioritize the treatment strategies for better patient outcome and discuss the controversies in treatment |
| 6 | C4.7.6 | To improve the skills on patient – centred approach to improve treatment satisfaction and perform patient counselling. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C5.1.1 | To study the regulations involved in drug discovery and drug development process. |
| 2 | C5.1.2 | To understand the regulatory guidelines and ethics of clinical trials. |
| 3 | C5.1.3 | To plan and construct pre-clinical trials and clinical trial activities. |
| 4 | C5.1.4 | To distinguish the roles and responsibilities of trial related personnel and designing of clinical trial documents. |
| 5 | C5.1.5 | To compare the regulatory aspect of clinical trials in India with other countries (USA and Europe). |
| 6 | C5.1.6 | To adapt and improve the skills in data management, safety monitoring and reporting to regulatory authorities. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C5.2.1 | To remember and recall the origin and need; measurement outcomes in pharmacoepidemiology and pharmacoeconomics. |
| 2 | C5.2.2 | To understand the pharmacoepidemiology. various concepts of risks in |
| 3 | C5.2.3 | To apply the concepts of pharmacoepidemiological methods in conducting various research studies with the help of case studies and available software’s. |
| 4 | C5.2.4 | To distinguish the pharmacoepidemiology. selected special applications of |
| 5 | C5.2.5 | To evaluate methods. the outcome by using various Pharmacoeconomic |
| 6 | C5.2.6 | To solve various case studies by applying the concepts of pharmacoepidemiology and Pharmacoeconomics in designing a good outcome. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C5.3.1 | To understand the basics of pharmacokinetics. |
| 2 | C5.3.2 | To demonstrate nomograms and tabulations and their applications in designing dosage regimens in special populations. |
| 3 | C5.3.3 | To apply the principles of pharmacokinetics in identifying the drug interactions. |
| 4 | C5.3.4 | To analyze GFR, creatinine clearance, extracorporeal removal of drugs and pharmacokinetic considerations in dosing renal and hepatic diseases. |
| 5 | C5.3.5 | To discuss bayesian theory, adaptive methods and pharmacogenetics in developing drug dosage regimens. |
| 6 | C5.3.6 | To develop the skills on individualization of drug dosage regimen in special population by considering TDM indications. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C5.4.1 | To elicit the patient's chief complaints, history of present illness, past medical history, social, family and occupational histories, complete review of systems for case study analysis. |
| 2 | C5.4.2 | To interpret the laboratory investigations in terms of the related pathophysiology. |
| 3 | C5.4.3 | To build effective and empathetical skills in counseling the patients on their medications and life style modifications. |
| 4 | C5.4.4 | To examine and demonstrate a new patient's case in a focused manner, chronologically developing the present illness, summarizing the pertinent positive and negative findings as well as the differential diagnosis and plans for further testing and treatment. |
| 5 | C5.4.5 | To estimate factors that frequently alter the effects of medications, including drug interactions and compliance problems. |
| 6 | C5.4.6 | To develop an ability to compile an assessment and plan for an individual patient organized by problem, discussing the likely diagnosis and plan of treatment. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C5.5.1 | To identify the societal issues related to health and pharmaceuticals and to report the aims and objectives of the project. |
| 2 | C5.5.2 | To review and compare the literature on selected topic/problem/issue. |
| 3 | C5.5.3 | To construct research plan and execute it accordingly. |
| 4 | C5.5.4 | To compile and analyze the data applying the knowledge of suitable statistical method to draw conclusion. |
| 5 | C5.5.5 | To measure short-term and long-term outcomes of a specific research to draw conclusion. |
| 6 | C5.5.6 | To propose new solutions and develop recommendations or guidelines to improve societal health outcomes. |
| S.No | CO NO. | Course Outcome |
|---|---|---|
| 1 | C6.0.1 | To relate the clinical knowledge in ward rounds for case analysis. |
| 2 | C6.0.2 | To interpret the results of the laboratory tests in terms of the related pathophysiology. |
| 3 | C6.0.3 | To interview the patient to provide better patient care by critical analysis. |
| 4 | C6.0.4 | To analyse each case to identify the drug related problems and overcome the burden on patients. |
| 5 | C6.0.5 | To take a part of health care team to bring better patient outcomes and drug information services. |
| 6 | C6.0.6 | To build an ability to choose critical area where interventions required for better pharmaceutical care. |